Profile data is unavailable for this security.
About the company
Jiangsu Yahong Meditech Co Ltd is a China-based company mainly engaged in drug research and development (R&D). The Company focuses on innovative drugs in the field of urogenital tumors and other major diseases. The product pipelines being developed by the Company include APL-1202, APL-1501, APL-1706, APL-1702, ASN-1764, ASN-1780, APL-1901, APL-1401, ASN-1733 and others. The Company is still in the R&D stage.
- Revenue in CNY (TTM)94.17m
- Net income in CNY-398.99m
- Incorporated2010
- Employees394.00
- LocationJiangsu Yahong Meditech Co LtdRoom 902 Technology BuildingNo.1 Yaocheng AvenueSHANGHAI 200126ChinaCHN
- Phone+86 2 168585280
- Fax+86 2 168585281
- Websitehttps://www.asieris.cn/cn/index.html
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 398.37m | 22.63m | 2.96bn | 787.00 | 130.86 | 4.04 | -- | 7.44 | 0.0593 | 0.0593 | 1.04 | 1.92 | 0.3728 | 1.48 | 1.87 | 506,185.00 | 2.12 | -4.59 | 2.99 | -6.24 | 47.94 | 24.09 | 5.68 | -18.40 | 1.43 | -- | 0.067 | -- | 5.54 | -2.50 | 137.33 | -- | -21.00 | -- |
| Qingdao Vland Biotech INC | 1.26bn | 78.59m | 3.23bn | 1.57k | 40.95 | 1.88 | -- | 2.55 | 0.3116 | 0.3116 | 5.01 | 6.77 | 0.432 | 3.49 | 4.07 | 804,705.90 | 3.70 | 5.78 | 5.78 | 7.89 | 45.41 | 46.13 | 8.57 | 10.34 | 0.8687 | 22.88 | 0.3127 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
| Bide Pharmatech Co Ltd | 1.10bn | 77.60m | 3.40bn | 846.00 | 43.18 | 1.72 | -- | 3.09 | 0.8669 | 0.8669 | 12.25 | 21.73 | 0.4687 | 1.02 | 4.83 | 1,301,939.00 | 3.26 | -- | 3.73 | -- | 38.92 | -- | 6.96 | -- | 5.04 | -- | 0.043 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
| Hinova Pharmaceuticals Inc | 109.74k | -229.37m | 3.55bn | 179.00 | -- | 2.78 | -- | 32,391.65 | -2.32 | -2.32 | 0.0011 | 12.92 | 0.00007 | 7.25 | 0.0054 | 613.07 | -14.92 | -31.86 | -16.50 | -37.18 | -400.96 | -- | -209,012.60 | -25,578.24 | 7.21 | -- | 0.036 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 455.90m | 102.18m | 3.71bn | 566.00 | 30.43 | 3.62 | -- | 8.14 | 0.4397 | 0.4397 | 1.82 | 3.70 | 0.2866 | 0.3598 | 8.66 | 805,473.80 | 6.79 | 8.83 | 7.81 | 9.61 | 61.34 | 61.49 | 23.70 | 26.85 | 3.13 | -- | 0.2729 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
| Jiangsu Yahong Meditech Co Ltd | 94.17m | -398.99m | 3.76bn | 394.00 | -- | 1.71 | -- | 39.95 | -0.6969 | -0.6969 | 0.1645 | 3.85 | 0.0366 | 11.12 | 5.92 | 239,007.60 | -15.55 | -15.80 | -16.49 | -16.48 | 77.85 | 55.32 | -424.48 | -9,445.91 | 10.12 | -- | 0.0711 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
| HitGen Inc | 410.39m | 45.10m | 4.61bn | 452.00 | 101.83 | 3.40 | -- | 11.23 | 0.1129 | 0.1129 | 1.03 | 3.38 | 0.2418 | 7.22 | 5.05 | 907,947.10 | 2.60 | 4.63 | 2.76 | 5.10 | 49.20 | 58.89 | 10.77 | 20.66 | 16.53 | 24.49 | 0.1431 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.44bn | 120.57m | 4.82bn | 584.00 | 39.23 | 2.69 | -- | 3.35 | 0.7192 | 0.7192 | 8.56 | 10.48 | 0.6254 | 1.58 | 3.70 | 2,465,474.00 | 6.48 | 5.31 | 8.22 | 6.76 | 83.02 | 86.02 | 10.36 | 8.10 | 3.22 | -- | 0.103 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Shanghai Medicilon Inc | 1.01bn | -269.57m | 4.85bn | 2.42k | -- | 1.99 | -- | 4.78 | -2.01 | -2.01 | 7.68 | 18.05 | 0.365 | 6.19 | 1.32 | 390,279.00 | -9.70 | 9.34 | -12.49 | 11.73 | 1.81 | 36.71 | -26.57 | 14.93 | 2.87 | -- | 0.0923 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.03bn | 215.33m | 4.88bn | 1.39k | 22.65 | 4.47 | -- | 4.72 | 1.92 | 1.92 | 9.23 | 9.73 | 0.5919 | 32.80 | 1.65 | 754,698.20 | 11.73 | 12.99 | 18.65 | 21.70 | 56.06 | 53.93 | 19.82 | 21.34 | 1.98 | 35.78 | 0.3065 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
Data as of Oct 09 2024. Currency figures normalised to Jiangsu Yahong Meditech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
17.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 20.85m | 7.38% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 6.77m | 2.40% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 5.97m | 2.11% |
| Zhonghai Fund Management Co., Ltd.as of 31 Dec 2023 | 3.57m | 1.26% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.32m | 1.18% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.18m | 0.77% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 2.02m | 0.72% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 1.94m | 0.69% |
| CITIC Securities Co., Ltd. (Invt Port)as of 31 Dec 2023 | 1.83m | 0.65% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 1.82m | 0.65% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
